Australian Pharmacist

Pfizer is now the COVID-19 vaccine of choice for some at-risk patients and those under 50 years of age in priority groups.

The state's major parties have committed to allowing pharmacist immunisers to access the National Immunisation Program (NIP) for the first time.

Barriers to medicine safety show a health system failing to properly support Australians with a disability, a new report from PSA reveals.

In a landscape of increasing opportunities for pharmacists, last week PSA launched its foundation stage training program for those wanting to work as a...

As the number of COVID-19 cases continues to rise in Australia, PSA is working to ensure pharmacists’ needs are considered in pandemic planning.

It’s no longer plain sailing in Australian community pharmacy. Bruce Annabel helps navigate in this, the fourth instalment of our Future Health series. Most...